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Abstract (max 250 words) 
Lewy bodies (LBs) are intra-neuronal inclusions consisting primarily of fibrillized human-α-Synuclein 
(hα-Syn) protein and represent the major pathological hallmark of Parkinson's disease (PD). Although 
doubling hα-Syn expression provokes LB pathology in humans, hα-Syn over-expression doesn’t trigger 
authentic LB formation in mice. We hypothesized that this could be attributed to interactions between 
exogenous hα-Syn and its endogenous mouse α-Syn (mα-Syn) homologue, and investigated whether hα-
Syn over-expression on mα-Syn KO backgrounds could promote hα-Syn fibrillization. Herein, we show 
that hα-Syn forms hyper-phosphorylated (at S129) and ubiquitin positive LB-like inclusions in mα-Syn KO 
primary neurons, as well as in transgenic mα-Syn KO mouse brains in vivo. Correlative light and electron 
microscopy, immuno-gold labelling and Thioflavin-S binding established their fibrillar ultrastructure, and 
FRAP/photo-conversion experiments showed that these inclusions grow in size and incorporate soluble 
proteins. Notably, hα-Syn inclusions were also observed upon knock-down of another mα-Syn homologue 
“β-Syn”, thereby proposing a role for these homologous proteins as natural inhibitors of abnormal 
aggregation. Mechanistically, our data show that mα-Syn preferentially interacts with aggregated hα-Syn 
PFFs species, and that such a “cross-species” interaction does not promote progressive aggregation in vitro 
and in vivo. As such, endogenous mα-Syn could be attenuating hα-Syn aggregation in mice via direct 
interaction and capping of early fibrillar forms. Altogether, our results provide novel primary neuronal and 
in vivo models for understanding mechanisms underlying hα-Syn intra-neuronal fibrillization, the 
contribution of this process to PD pathogenesis, and for screening pharmacologic and genetic modulators 
of α-Syn fibrillization in neurons.  
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Significance Statement (max 120 words) 
Although it has been established for over 100 years that Lewy bodies (LBs) represent the major pathological 
hallmark of Parkinson's disease (PD), we still do not know why these fibrillar intra-neuronal inclusions of 
the α-Synuclein (α-Syn) protein form, and how they contribute to disease progression. One of the major 
causes underlying this gap in knowledge is the unavailability of animal models that truly reproduce the 
formation of LBs. In this study, we show that the lack of hα-Syn fibrillization into LBs in mouse models 
can be attributed to interactions between hα-Syn and its endogenously expressed mouse α-Syn homologue. 
Moreover, we provide novel well-characterized primary neuronal and in vivo models which recapitulate the 
main molecular feature of PD; bonafide α-Syn fibrillization. 
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Introduction 
The aggregation of proteins into fibrillar structures is a key hallmark of many neurodegenerative disorders. 
In Parkinson's disease (PD), α-synuclein (α-Syn), a predominantly pre-synaptic protein involved in 
regulation of neurotransmitter release, abnormally fibrilizes and forms intra-neuronal inclusions termed 
Lewy bodies (LBs)(1, 2). So far, the mechanisms underlying LB formation remain poorly understood, and 
the impact of LB presence on neuronal viability remains controversial, in part due to the lack of animal 
models recapitulating α-Syn fibrillization into authentic LBs.  
Since patients with familial history of parkinsonism were found carrying either multiplications or point 
mutations of the α-Syn gene “SNCA”(2),  most animal models of PD have been generated by over-
expressing wild-type (WT) human α-Syn (hα-Syn) or mutant forms linked with familial PD(3). Strikingly, 
whereas rodent models expressing hα-Syn do not recapitulate the formation of authentic LBs comprising 
fibrillar α-Syn within dopaminergic neurons, hα-Syn over-expression in Drosophila led to dramatic 
neuronal loss accompanied with fibrillar LB-like structures(4). The fact that Drosophila, unlike rodents, 
lack expression of an endogenous α-Syn homologue implied that hα-Syn fibril formation could be more 
favorable in models lacking endogenous α-Syn expression. Subsequent experiments in mice supported this 
suggestion, as hα-Syn transgenic (Tg) mice lacking endogenous mα-Syn exhibited exacerbated pathology 
compared to WT counterparts(5), and manifested fibrillar/granular accumulations in the olfactory bulb(6). 
Explaining this effect, in vitro “test-tube” experiments  remarkably showed that small amounts of mouse 
α-Syn (mα-Syn) directly inhibit the fibrillization of purified hα-Syn protein in solution(7). 
Despite all of these interesting observations, it remained unclear whether endogenously expressed 
Synuclein homologues directly inhibit hα-Syn aggregation in neurons, and whether ectopic hα-Syn 
expression in their absence would allow de novo hα-Syn fibrillization events. Therefore, we systematically 
evaluated the propensity of hα-Syn to aggregate on Synuclein KO backgrounds. Using a battery of 
biochemical and imaging techniques, we demonstrate that in cultured primary neurons and brains of mα-
Syn KO mice, over-expressed hα-Syn readily aggregates into inclusions that exhibit several similarities 
with LBs in terms of solubility, immuno-reactivity and amyloidogenicity, and represent a bonafide 
fibrillization process as revealed by serial-section transmission electron microscopy (ssTEM), live imaging, 
and response to pharmacological aggregation inhibitors. Similarly, primary neurons lacking expression of 
β-Syn (β-Syn-/-) or all three homologues (α- β- and γ- Syn) also manifest enhanced hα-Syn aggregation, 
thereby suggesting  that the presence of endogenous Synuclein homologues may represent a natural 
mechanism regulating abnormal α-Syn aggregation. To dissect this mechanism, we performed immuno-
precipitation and surface plasmon resonance experiments which intriguingly showed that mα-Syn 
preferentially interacts with aggregated hα-Syn PFFs species rather than monomers. Importantly, in vitro 
aggregation experiments and in vivo assessment of cross-seeding propensities showed that the observed 
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“cross-species” interactions do not promote progressive seeding and spreading of aggregates. These 
findings provide a possible explanation as to why current rodent PD models expressing hα-Syn do not 
exhibit pronounced hα-Syn fibrillization, and provide models that reproduce a critical pathological feature 
of the disease: the de novo formation of fibrillar hα-Syn aggregates. 
 
Results 
Induction of hα-Syn inclusion formation in SNCA-/- primary neurons  
Several studies have previously reported that over-expressed hα-Syn in mouse primary neurons exhibits 
diffuse localization without forming discreet inclusions (8-11). To assess whether the absence of mα-Syn 
would affect this distribution, we examined the localization of transiently expressed hα-Syn in primary 
neurons derived from C57Bl6/J/ola/hsd mice (SNCA-/-) lacking expression of mα-Syn(12) (Fig. S1A-B). 
Interestingly, whereas hα-Syn exhibited the previously reported diffuse distribution in WT neurons, a 
significant proportion of the SNCA-/- neurons developed spheroid-like inclusions that were consistently 
observed in close association with nuclear and cytoplasmic membranes (Fig. 1A and Video S1). A similar 
phenotype was observed in primary neurons derived from another SNCA-/- mouse strain (B6,129X1-
Sncatm1Rosl/J) generated by targeted deletion of two exons of the mα-Syn gene(13) (Fig. S2C-D), thereby 
establishing that inclusion formation is directly linked to the specific loss of mα-Syn expression. In line 
with this, re-expression of mα-Syn in SNCA-/- neurons significantly reduced the formation of intra-neuronal 
hα-Syn inclusions, and restored the diffuse distribution of hα-Syn in most neurons (Fig. 1B). 
To investigate whether the total abolishment of mα-Syn expression is necessary to promote hα-Syn 
inclusion formation, we assessed whether decreasing mα-Syn levels in WT neurons via shRNA mediated 
silencing is sufficient to promote this process. Transient expression of three different vectors encoding 
shRNA hairpin loops (Fig. S2A) showed efficient silencing of mα-Syn in transfected neurons compared to 
those transfected with scrambled shRNA sequences (Fig. S2B), and biochemical analysis of lentivirally 
infected neurons showed over 50% reduction in mα-Syn expression (Fig. S2C). Notably however, silencing 
mα-Syn did not promote hα-Syn inclusion formation in WT neurons (Fig. S2D), suggesting that even low 
levels of mα-Syn levels are sufficient to attenuate inclusion formation. 
  
hα-Syn inclusions reproduce key LB features and exhibit fibrillar ultrastructure 
Several cellular models manifesting α-Syn accumulation into inclusions in human cell lines have been 
previously reported, either upon α-Syn over-expression alone(14-16), co-expression with synphilin-1(17), 
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exposure to proteasome inhibitors(9), or application of oxidative/nitrative insults(18, 19). Nevertheless, 
inclusions observed under these conditions typically don’t reproduce all key LB features, including 
decreased solubility, hyper-phosphorylation at Serine-129 (pS129)(20), ubiquitination(21), Thioflavin-S 
binding, and fibrillar ultra-structural organization(1). Therefore, we assessed whether hα-Syn inclusions 
observed in SNCA-/- neurons fulfil these criteria. 
To determine whether inclusion formation is linked with decreased hα-Syn solubility, WT or SNCA-/- 
neurons were infected with lentiviruses encoding hα-Syn and then fractionated into nonionic detergent-
soluble and nonionic detergent-insoluble fractions. Using this assay, lentivirally infected SNCA-/- neurons 
showed significantly less monomeric hα-Syn in detergent-soluble fractions compared to WT counterparts 
(Fig. 1C). Interestingly, this effect was not due to decreased total hα-Syn expression in the SNCA-/- neurons, 
as similar total hα-Syn RNA and protein levels were observed in unfractionated WT and SNCA-/- neurons 
(Fig. S3A-B). In contrast, the decrease in soluble monomeric hα-Syn was concomitant with the appearance 
of high molecular weight (HMW) hα-Syn species in detergent-insoluble fractions of lentivirally infected 
SNCA-/- neurons (Fig. 1C). To validate our fractionation protocol, we treated control neurons with insoluble 
hα-SynAlexa633 preformed fibrils (PFFs, characterized in Fig. S4), which showed strong signal almost 
exclusively within detergent-insoluble fractions as previously reported (Fig. 1C)(22). Altogether, these 
results suggest that abolishing mα-Syn expression enhances the aggregation propensity of hα-Syn in 
primary neurons, as reflected by decreased solubility and the formation of insoluble HMW aggregates. 
One possibility is that the inclusions reflect aggregated hα-Syn that is contained within vesicles of the 
endo-lysosomal pathway. As such, we systematically assessed inclusion co-localization with specific 
markers for early endosomes (Rab5 and RhoB), late endosomes (Rab7), lysosomes (Lamp1), 
autophagosomes (LC3) and multi-lamellar bodies (CD63). As shown in Fig. S5, although some hα-Syn 
inclusions showed weak partial co-localization with co-transfected markers of late endosomes (Rab7-GFP) 
and lysosomes (Lamp1-RFP), indicating potential degradation by this pathway, most of the inclusions 
showed no colocalization with any of the transfected markers. As such, these findings rule out the possibility 
of all inclusions being merely vesicles of the endo-lysosomal pathway.  
Next, we assessed whether the inclusions formed in SNCA-/- neurons are readily detectable using 
common LB probes; namely antibodies against α-Syn(1), pS129-α-Syn(20) and ubiquitin(21), as well as 
Thioflavin-S(23). As shown in Figure 1D, immuno-staining using nine different anti-α-Syn antibodies with 
epitopes spanning most of the α-Syn sequence all revealed bright spheroid intra-neuronal inclusions, 
thereby establishing that these structures indeed comprise hα-Syn which is not necessarily truncated at any 
of its termini. Moreover, dual immuno-fluorescence analysis showed that hα-Syn positive inclusions are 
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also hyper-phosphorylated at S129 and are ubiquitinated, and co-staining with Thioflavin-S indicated that 
the inclusions could comprise cross-β-sheet fibrillar content (Fig. 1E). 
To establish whether the hα-Syn inclusions comprise fibrillar ultrastructure, we performed correlative 
light and electron microscopy (CLEM) analysis that allows ultra-structural examination of neurons 
previously identified by confocal microscopy as containing fluorescent inclusions (Fig. 2A-C). 72 hours 
(hrs) post-transfection, hα-Syn inclusions were detected in close association with nuclear and cytoplasmic 
membranes or near mitochondria, but were rarely found surrounded by a uniform lipid bilayer (Fig. 2B-C), 
thereby further ruling out the possibility of inclusions being vesicular in nature. Remarkably, high 
magnification ssTEM of the correlated inclusions revealed intertwining “whirls” of filamentous structures 
in most analyzed inclusions (Fig. 2B-C). Individual measurements of these structures showed that the 
filaments have an average diameter ranging between 7-13 nm (Fig. 2D), which is similar to that of fibrils 
within genuine LBs (24), thereby suggesting that hα-Syn could be aggregating into fibrils within these 
inclusions.  
Alternatively, these observed “whirls” could represent membranous structures that have been entrapped 
within inclusions. To address this possibility, we performed an additional CLEM experiment where we 
treated neurons exhibiting de novo aggregates (composed of Myc-hα-Syn) with hα-SynAlexa633 PFFs for 24 
hrs, and compared within adjacent neurons, the ultrastructure and diameter of de novo filaments 
(comprising only Myc-hα-Syn) compared to internalized PFFs, mixtures of both, as well as to intracellular 
membranes. As shown in Figure S6, whereas intracellular membranes showed a broad diameter distribution 
ranging from 7-12 nm with a mean average of 8.7 nm, internalized PFFs and mixtures of de novo formed 
filaments and PFFs showed a much more defined width distribution of 10-13 nm and higher mean diameter 
of ~11 nm. Interestingly, although filaments in de novo inclusions exhibited a more broad width distribution 
than PFFs and mixtures being 7-13 nm, with some of the filaments having low diameter that could classify 
them as membranous, the vast majority (~75%) were in the range of 10-13 nm, which falls within the 
narrow distribution of PFFs and thereby supports their fibrillar nature. 
To determine whether hα-Syn is the constituent of the observed fibrillar structures, we sought to assess 
their reactivity with antibodies against α-Syn by immuno-gold labelling. First, we probed the ability of four 
different antibodies (having different epitopes against the N-terminus, C-terminus and NAC region of α-
Syn) to detect hα-Syn PFFs. Notably, we found that polyclonal anti-PAN-Syn antibodies such as the ab-
6176 and FL-140 detect PFFs much more readily than monoclonal hα-Syn specific antibodies (Fig. S7). 
Therefore, we assessed the reactivity of the fibrillar structures observed within SNCA-/- neurons expressing 
hα-Syn to the ab-6176 antibody. Importantly, 3D reconstruction of ssTEM images clearly showed immuno-
gold particles reacting with outer and inner portions of the whirls of filaments detected within inclusions 
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(Fig. 2E-F), thereby confirming Synuclein presence within these structures. 
Altogether, these findings demonstrate that the inclusions observed in SNCA-/- neurons exhibit several 
similarities with LBs in terms of solubility and immuno-reactivity, and demonstrate signs of bonafide 
fibrillization events. However, the filaments do not have an orderly arrangement with a dense core as 
typically observed in brainstem LBs, but are embedded amongst an electron translucent medium, which is 
probably sequestered soluble α-Syn protein. As the filaments exhibit a disordered distribution, they may 
recapitulate early stages of LB formation, which may need more time or additional factors to mature and 
remodel into authentic LBs.  
  
hα-Syn inclusions in SNCA-/- neurons grow in size and incorporate soluble α-Syn 
We then investigated whether hα-Syn aggregation kinetics can be accurately evaluated in our novel 
neuronal model. In SNCA-/- neurons transiently expressing hα-Syn, inclusions were detected 24, 48 or 72 
hrs post-transfection, and the size of inclusions appeared to increase over time as assessed by quantifying 
3D-rendered inclusion volumes, with maximum size reached at 48 hrs post-transfection (Fig. 3A). To 
investigate the mechanisms underlying inclusion growth, we performed fluorescence live imaging 
experiments using hα-Syn that is N-terminally tagged to “mEOS2”, a fluorescent protein that is photo-
convertible from bright green (506 nm) to orange-red (584 nm) when excited at near-ultraviolet 
wavelengths(25). As shown in Figure 3B, somatic and neuritic mEOS2-α-Syn inclusions were detected 24 
hrs post-transfection in SNCA-/- neurons, and these continued to grow in volume over 72 hrs. Moreover, the 
detected inclusions were reactive with antibodies against total α-Syn, ubiquitin, and pS129-α-Syn (Fig. 3C), 
thereby suggesting that the fusion protein reproduces the aggregation properties of untagged hα-Syn, and 
could be used to investigate the kinetics of this process in neurons.  
Short interval (~1 hr) confocal live imaging followed by 3D surface rendering showed that the volume 
of individual inclusions increased over ~1 hr of imaging, with very few reversible fusion events noted (Fig. 
3D). Moreover, analysis of the speed of moving particles showed that most detected inclusions are 
immobile (Fig. 3D), thereby ruling out the possibility of inclusion growth being mainly caused by fusion 
of small motile aggregates. Notably, the percent increase in volume was variable between different 
inclusions, with some doubling their volume within 50 minutes and others showing modest changes. This 
observation suggests that inclusion growth rate is not linear and constant over time, and is not necessarily 
similar for the whole population of inclusions within the same neuron. 
To determine whether mEOS2-α-Syn inclusions incorporate soluble hα-Syn over time, we performed 
fluorescence recovery after photo-bleaching (FRAP) and photo-conversion live imaging experiments (Fig. 
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3E), which allow assessing rates of protein diffusion into (DIN) and out-of (DOUT) inclusions respectively, 
as well as determining the relative proportion of immobile protein within inclusions (immobile fraction, 
IF). In FRAP experiments, we photo-bleached individual inclusions and monitored the recovered 
fluorescence from diffusing soluble cytosolic protein. As shown in Figure 3F and Video S2, FRAP 
measurements displayed consistent recovery of fluorescent signal within photo-bleached inclusions, and 
mono-exponential fitting of FRAP plots from ~90 different inclusions allowed the estimation of DIN and 
IF. The average value for DIN was very low (~0.03 µm2/sec), consistent with previous results for 
immobilized α-Syn-tetracystein inclusions in SH-SY5Y cells (0.03-0.04 µm2/sec)(26), thereby suggesting 
the presence of a structure that impedes free diffusion. In line with this, ~32% of the protein was estimated 
to be found within the IF, thereby establishing that inclusions comprise immobilized proteins that are unable 
to equilibrate with the cytoplasmic pool, likely due to their binding to a dense compact structure. The 
presence of high amounts of soluble mobile protein (~68%) within inclusions is in line with our ssTEM 
data showing filamentous structures being embedded within a bulk of electron translucent milieu, which is 
most probably sequestered soluble protein. 
In order to assess the DOUT, we utilized the photo-convertible property of mEOS2, where we photo-
converted individual inclusions by near-ultraviolet irradiation, and monitored the decrease in photo-
converted fluorescence intensity within inclusions. The decay in fluorescence would reflect outward 
diffusion of proteins from the inclusions to the cytosol. As expected, irradiation of inclusions with a 405 
nm laser successfully resulted in the photo-conversion of 488 nm mEOS2-α-Syn fluorescence to 568 nm 
(Fig. 3G and Video S3). Strikingly, whereas exponential fitting of decay curves from ~50 different neurons 
revealed a slightly lower estimation of the IF compared to that obtained from FRAP experiments (16 
±10%), the estimated DOUT (0.0022 ±0.0007 µm2/sec) was almost 16 folds lower than DIN (Fig. 3H). This 
suggests that within the same time fraction, significantly more protein is going into inclusions compared to 
soluble protein that is diffusing out. As such, these findings together suggest that hα-Syn aggregates in 
SNCA-/- neurons incorporate soluble protein into highly stable structures, most likely the fibrils observed 
by ssTEM. 
  
Inclusion formation in SNCA-/- neurons is an aggregation-driven process 
To further establish whether hα-Syn inclusion formation is an aggregation-driven process, we assessed 
whether altering the aggregation propensity of hα-Syn affects formation and/or growth of neuronal 
inclusions. Two modified hα-Syn proteins, a C-terminally truncated variant (at position 120) that has been 
shown to aggregate more readily than full-length α-Syn in vitro and in vivo(27), and a variant with the S87E 
substitution that inhibits hα-Syn aggregation in similar models(28, 29) were expressed in WT or SNCA-/- 
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neurons. As shown in Figure 4A, while similar proportions of SNCA-/- neurons expressing full-length (α-
SynFL) or truncated (α-Syn∆120) hα-Syn developed inclusions, the S87E aggregation-deficient variant mostly 
exhibited diffuse distribution. This effect was not due to a difference in protein expression levels between 
the three proteins as similar mean fluorescence levels per neuron were detected across conditions (Fig. S8).  
As that the α-Syn∆120 mutant could be affecting the size of individual aggregates, we investigated kinetics 
of mEOS-α-Syn inclusion growth by live imaging (Fig. 4B-C). Surface reconstruction of inclusions in 50 
neurons per condition showed that mEOS2-α-Syn∆120 forms significantly larger inclusions 24 hrs post-
transfection compared to mEOS2-α-SynWT (Fig. 4C). In contrast, the few inclusions formed by the mEOS2-
α-SynS87E mutant were much smaller at 48 hrs (Fig. 4C). In a complementary strategy, we investigated 
whether treatment with a pharmacological aggregation inhibitor “Tolcapone”(30) would affect inclusion 
formation in this model. Remarkably, Tolcapone treatment reduced inclusion formation by ~60% and 
restored the diffuse distribution of hα-Syn in SNCA-/- neurons (Fig. 4D). As such, these results together 
demonstrate that inclusion formation in SNCA-/- neurons is aggregation-driven, as introducing a single 
amino-acid substitution known to inhibit hα-Syn aggregation propensity or treatment with a known 
aggregation inhibitor significantly attenuate inclusion formation. 
 
Endogenous β-Syn KO is a natural hα-Syn aggregation inhibitor in neurons 
An attractive general implication of our findings is that homologous members of the synuclein family could 
naturally act as physiological inhibitors of abnormal α-Syn aggregation. Therefore, we assessed whether 
the other members of the synuclein family, β-Syn and γ-Syn, exert a similar inhibitory effect on hα-Syn 
aggregation. To test this, we prepared neuronal cultures from mice lacking β-Syn (β-Syn KO)(31), γ-Syn 
(γ-Syn KO)(32), or all three synucleins (triple KO)(33). Loss of α- and β-Syn in corresponding KO cultures 
was validated by immunocytochemistry (Fig. 5A), and γ-Syn expression was not detectable in any of the 
cultures, probably due to its low expression levels in hippocampal neurons as previously reported(34). 
Remarkably, when we assessed the distribution of exogenously expressed hα-Syn across the different 
cultures (Fig. 5B), we found that β-Syn KO and triple KO neurons similarly develop LB-like inclusions, 
unlike WT controls and γ-Syn KO neurons that mostly exhibit diffuse hα-Syn distribution. Importantly, the 
inclusions formed in β-Syn KO and triple KO neurons were also hyper-phosphorylated at S129, hence 
exhibiting a key pathological LB-like phenotype (Fig. 5C). These findings suggest that unlike endogenous 
γ-Syn, the other two homologues α-Syn and β-Syn have similar inhibitory effects on ectopic hα-Syn 
aggregation. Importantly however, as similar percentages of β-Syn KO and triple KO neurons develop 
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inclusions (~35%), this intriguingly rules out the presence of a synergistic effect for the deletion of both 
proteins. 
  
The absence of mα-Syn promotes specific aggregation of hα-Syn in vivo 
To test whether the presence of mα-Syn affects the aggregation propensity of hα-Syn in the brain, we 
generated mice lacking endogenous mα-Syn (SNCA-/-)(13) and carrying two copies of hα-Syn(hα-
Syn+/+)(35) (Fig. S9A). Biochemical fractionation of brain homogenates into cytosolic (soluble) and 
particulate (insoluble) protein fractions was performed to assess whether these mice (hα-Syn+/+SNCA-/-) 
exhibit changes in hα-Syn aggregation and solubility, compared to hα-Syn+/+ controls expressing 
endogenous mα-Syn. In line with our previous data, less monomeric hα-Syn was detected in soluble 
fractions derived from hα-Syn+/+SNCA-/- mice compared to hα-Syn+/+ counterparts (Fig. 6A). This decrease 
in monomeric hα-Syn was concomitant with the appearance of HMW hα-Syn species within insoluble 
fractions, which were detected using three different antibodies against hα-Syn thereby establishing their 
specificity (Fig. 6A, Fig. S9B). Moreover, the decrease in soluble hα-Syn was not due to decreased total 
hα-Syn expression in hα-Syn+/+SNCA-/- mice compared to hα-Syn+/+ counterparts, as similar total hα-Syn 
mRNA and protein levels were observed in unfractionated brains of both genotypes (Fig. S9C-D). As such, 
these findings altogether suggest that hα-Syn is readily aggregating and becoming less soluble in the 
absence of mα-Syn in Tg mouse brains. 
To further evaluate the extent of in vivo hα-Syn aggregation, we performed immuno-histochemical 
analyses on sections treated with proteinase-K, which allows selective visualization of resistant aggregates. 
Consistent with previous studies (35), hα-Syn+/+ mice showed abundant intra-neuronal α-Syn 
immunoreactive inclusions in the cortex, of which some were proteinase-K resistant (Fig. 6B). Strikingly, 
cortical and striatal neurons from hα-Syn+/+SNCA-/- mice showed higher immunoreactivity to anti-α-Syn 
antibodies and exhibited a significant increase in proteinase-K resistant inclusions in the cortex and 
hippocampus (Fig. 6B). Moreover, double immuno-labelling experiments showed that inclusions are 
phosphorylated at S129, and exhibit strong reactivity for the synaptic vesicle protein synaptophysin (Fig. 
6C-D), both of which being markers of LB pathology (20, 36). Taken together, these findings demonstrate 
that the aggregation propensity of hα-Syn is enhanced in the absence of mα-Syn in vivo, as reflected by 
decreased solubility and accumulation of hα-Syn into proteinase-K resistant inclusions. 
To assess whether abolishing of mα-Syn expression would promote the aggregation of human β-
synuclein (hβ-Syn), the considerably less aggregation prone homologue of hα-Syn, we crossed transgenic 
mice expressing hβ-Syn(37) with mα-Syn null mice to generate hβ-Syn+/+SNCA-/- transgenics. Biochemical 
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fractionation revealed that in contrast to the promotion of hα-Syn aggregation, the absence of mα-Syn did 
not affect the levels of soluble hβ-Syn or cause the appearance of insoluble hβ-Syn species (Fig. S10A). In 
addition, immuno-histochemical analysis showed that hβ-Syn was mostly localized within neuronal 
terminals and did not show any inclusions neither in brains of hβ-Syn+/+ mice as previously reported (37), 
nor in brains of hβ-Syn+/+SNCA-/- mice (Fig. S10B). As such, these results show that α-Syn ablation does 
not promote the aggregation of hβ-Syn in vivo, thereby conferring specificity to the effect we observe in 
hα-Syn+/+SNCA-/-  mice.  
 
mα-Syn interacts with aggregated hα-Syn species attenuating seeding and spreading 
To investigate the mechanism via which mα-Syn affects hα-Syn aggregation, we first assessed whether 
over-expressed hα-Syn directly interacts with endogenous mα-Syn in WT primary neurons. Notably, we 
did not detect any interaction between the two proteins at the monomer level by co-immuno-precipitation 
(Fig. S11A). To investigate whether mα-Syn interacts with multimeric/aggregated hα-Syn species rather 
than hα-Syn monomers, we assessed the interaction of mα-Syn monomers with equimolar amounts of hα-
Syn monomers or hα-Syn sonicated fibrils (PFFs; characterized in Fig. S12). Intriguingly, mα-Syn was co-
immuno-precipitated only when it was mixed with hα-Syn PFFs and not the hα-Syn monomers (Fig. 7A), 
indicating that monomeric mα-Syn preferentially interacts with hα-Syn PFFs in vitro. In order to confirm 
these findings and to obtain a quantitative assessment of the interaction between mα-Syn monomers and 
hα-Syn PFFs by an independent readout, we performed surface plasmon resonance (SPR) measurements. 
Briefly, saturating amounts of either hα-Syn monomers or hα-Syn PFFs were immobilized by amine 
coupling to separate CM5 chips, and then increasing concentrations of mα-Syn monomers were flushed on 
to the chips. As shown in Figure 7B, and in line with our immuno-precipitation experiments, no interaction 
was noted between injected mα-Syn monomers and immobilized hα-Syn monomers, even at the highest 
tested concentration for mα-Syn (10 µM). In contrast, mα-Syn monomers readily interacted with hα-Syn 
sonicated PFFs in a dose dependent manner, even at concentrations as low as 0.1 µM. 
To investigate whether endogenous mα-Syn similarly interacts with aggregated hα-Syn species in 
primary neurons, we treated WT neurons with sonicated hα-Syn PFFs and assessed interaction by immuno-
precipitation and immuno-fluorescence analyses. Importantly, and in line with our in vitro results, mα-Syn 
co-immuno-precipitated with pulled down hα-Syn PFFs (Fig. S11B). Moreover, confocal imaging revealed 
that internalized hα-Syn PFFs colocalize with endogenous mα-Syn (Fig. S11C), which radically 
redistributes from diffuse somatic localization into defined puncta as previously described (22). Altogether, 
these results show that mα-Syn preferentially interacts with aggregated hα-Syn PFFs in vitro and in neurons.  
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Next, we explored whether such an interaction between α-Syn PFFs and α-Syn monomers from different 
species would seed or alternatively attenuate progressive monomer aggregation. As such, we assessed 
aggregation kinetics of hα-Syn or mα-Syn monomers in the presence of either hα-Syn PFFs or mα-Syn 
PFFs (characterized in Fig. S12). Strikingly, assessment of Thioflavin-T binding, remaining monomer 
content and fibrillar morphology by electron microscopy all consistently showed that the fibrillization α-
Syn monomers is predominantly accelerated (seeded) in the presence of α-Syn PFFs of the same species. 
For instance, whereas the lag phase was eliminated in the mixture of hα-Syn monomers and hα-Syn PFFs 
resulting in the appearance of fibrillar structures as of 8 hrs of incubation (Fig. 7C-F), the aggregation 
kinetic of the mixture of hα-Syn monomers and mα-Syn PFFs was similar to that of hα-Syn alone, where 
only oligomeric species were formed at 8 hrs of incubation. Similar observations were noted for the mixture 
mα-Syn monomers and mα-Syn PFFs, which showed the most dramatic elimination of the lag phase, and 
formation of fibrils after only 2 hrs of incubation (Fig. S13A-D). Here again, the addition of hα-Syn PFFs 
to mα-Syn monomers failed to promote aggregation to a similar extent, only forming oligomeric species at 
2 hrs. Altogether, these findings strongly show that α-Syn aggregation kinetics are significantly accelerated 
when the seeds and monomers are from the same species, and that the presence of mixed species of 
monomers and PFFs results in in less seeding propensity and slower aggregation kinetics. 
To evaluate whether the seeding and spreading potential of α-Syn PFFs is similarly affected upon having 
PFFs and endogenous monomers of the same species in the brain, we injected either mα-Syn PFFs or hα-
Syn PFFs into the striatum of WT (non-transgenic) or SNCA-/- mice (as controls), and then compared the 
seeding and spreading propensity in different brain regions one month post-injection. Strikingly, we 
observed most pronounced spreading α-Syn pathology when mα-Syn PFFs were injected into WT mice 
expressing endogenous mα-Syn (Fig. 8G), as mα-Syn accumulated into somatic inclusions that are 
ubiquitinated and hyperphosphorylated at S129 in the cortex and amygdala (Fig. S13E). In contrast, hα-
Syn PFFs induced significantly less pathology at these regions in WT mice at the same time-point. 
Moreover, SNCA-/- mice showed very limited overall pathology following injection with either hα-Syn PFFs 
or mα-Syn PFFs, indicating that the observed inclusions in WT mice injected with mα-Syn PFFs reflect the 
seeding and propagation of endogenous mα-Syn. Altogether, these findings show that in vitro and in vivo, 
α-Syn PFFs preferentially seed the aggregation of monomeric α-Syn of the same species, and therefore, the 
interaction of monomers and PFFs from different species does not promote progressive seeding and 
spreading of pathology. 
 
Discussion 
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The aggregation of α-Syn into LBs has been directly linked to the pathogenesis of PD(2). The mechanism 
of formation and the precise effect of LBs on neuronal physiology and viability remains poorly understood, 
mostly due to the lack of animal and cellular models exhibiting de novo α-Syn fibrillization into authentic 
LB-like structures. Although doubling α-Syn expression is sufficient to cause PD in humans, attempts to 
reproduce molecular PD pathology based on α-Syn over-expression in various animal models have not been 
successful. This could imply the presence of cellular factors that inhibit hα-Syn aggregation in these models. 
In this study, we sought to systematically examine whether endogenous α-Syn homologues attenuate hα-
Syn aggregation in neurons. Using different Synuclein KO cultures, we found that a substantial fraction of 
SNCA-/- neurons expressing hα-Syn develop inclusions that exhibit key LB-like features, including S129 
hyper-phosphorylation, ubiquitination and Thioflavin-S reactivity. Importantly, this phenomenon reflected 
de novo hα-Syn fibrillization as revealed by ssTEM following both CLEM and immuno-gold labelling 
experiments. To the best of our knowledge, these features have not been altogether reported in any of the 
previously published cellular models that rely on the sole over-expression of hα-Syn. 
Multiple lines of evidence from many of our experiments further converged to establish that inclusion 
formation SNCA-/- neurons is an aggregation driven process. Over-expression of the aggregation 
incompetent mutant S87E or treatment with the pharmacological aggregation inhibitor “Tolcapone” 
resulted in marked reduction in inclusion formation. In contrast, overexpression of the aggregation-prone 
truncated hα-Syn variant (1-120) resulted in the formation of larger inclusions compared to the WT protein. 
In all cases where we observed increased inclusion formation, we also observed decreased hα-Syn solubility 
and the appearance of HMW aggregates, concomitant with the loss of monomers. Moreover, time-lapse 
live imaging coupled with FRAP and photo-conversion experiments showed in real time that the inclusions 
grow in size and readily incorporate soluble hα-Syn protein. Interestingly however, when we explored the 
toxic potential of these inclusions, we found that the aggregates formed do not provoke increased toxicity 
(SI Text, Fig. S14-15), consistent with previous studies suggesting that intracellular hα-Syn aggregates may 
be protective in cellular models (38, 39). 
Having established that SNCA-/- primary neurons are more permissive for hα-Syn aggregation in culture, 
we sought to validate this finding in vivo. Two previous independent studies had suggested that expression 
of hα-Syn∆120 or hα-SynA53T in Tg mice lacking mα-Syn expression leads to the formation of fibrillar 
inclusions within the Substantia nigra or spinal cord respectively(5, 6). Therefore, we directly compared 
the aggregation propensity of Tg hα-Syn in brains of mice expressing mα-Syn(35), or having no 
endogenous mα-Syn expression. Our data showed that hα-Syn exhibits enhanced aggregation propensity in 
the absence of mα-Syn, which was reflected by decreased solubility, enhanced detection of HMW 
oligomeric species, and formation of abundant proteinase-K resistant and pS129 hyper-phosphorylated 
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inclusions. In order to rule out the possibility that knocking out mα-Syn promotes nonspecific aggregation, 
we conducted similar studies on hβ-Syn, an α-Syn homologue which is significantly less prone to aggregate. 
As expected, knocking out mα-Syn did not affect the levels, distribution or staining pattern of hβ-Syn in 
transgenic mice. 
Our observation that the re-introduction of mα-Syn in SNCA-/- neurons significantly attenuates hα-Syn 
inclusion formation suggests that the mouse homologue could be directly inhibiting hα-Syn aggregation. 
Intriguingly, although we could not detect prominent interaction between human and mα-Syn at the 
monomeric level in neurons, we consistently observed that mα-Syn preferentially interacts with sonicated 
PFFs in vitro, and in neurons. Moreover, we found that this interaction does not promote progressive 
seeding and spreading of pathology in vitro or in mouse brains in vivo. As such, endogenous mα-Syn could 
be directly inhibiting hα-Syn fibrillization in WT primary neurons by stabilizing oligomeric species and 
capping terminals of early fibrillar stretches formed by hα-Syn (Fig. 7H).This proposition is well in line 
with the previous study by Rochet et al.(7) showing that in vitro, mα-Syn inhibits the fibrillization of hα-
Syn by stabilizing oligomers on the pathway to amyloid formation. Moreover, it is consistent with literature 
reports which imply that the propagation and spreading of α-Syn pathology is prominent under conditions 
where the injected PFFs and host expressed monomers are from the same species. In most of these studies, 
seeding and spreading of α-Syn pathology was observed when mα-Syn PFFs was injected in non-transgenic 
mice expressing mα-Syn (40-42), or when hα-Syn PFFs were injected into transgenic mice expressing 
human α-Syn protein (43-48). 
An attractive general implication of our findings is that aggregation attenuation by homologous proteins 
could represent a generic biological phenomenon. This proposition is in harmony with multiple studies 
reporting decreased aggregation kinetics in the presence of amyloidogenic homologous proteins underlying 
different diseases. For instance, the key peptides involved in the formation of amyloid plaques in 
Alzheimer’s disease, Aβ40 and Aβ42, were shown to reciprocally inhibit each other’s aggregation in vitro 
in a concentration dependent manner(49). Moreover, mutant hemoglobin β-chain polymerization in sickle 
cell anemia was shown to be attenuated upon increasing ratios of its γ-chain homologue(50). Likewise, in 
transthyretin (TTR) amyloid diseases, murine/human TTR homologues form hetero-tetramers that impair 
amyloid formation(51, 52), and aggregation in vivo was achieved mostly in Tg mice expressing TTR 
mutants on an endogenous TTR KO background(52). Finally, the aggregation kinetics of the “islet amyloid 
polypeptide” (IAPP) in bulk solution were shown to be dramatically affected by the presence of its rat 
homologue (53, 54).  
In light of all these findings, we investigated whether this phenomenon could be extended to the other 
endogenous hα-Syn homologues; β-Syn and γ-Syn. Interestingly, we found that β-Syn KO cultures also 
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developed hα-Syn inclusions that were hyper-phosphorylated as S129. In contrast, the distribution of hα-
Syn was not affected when expressed in γ-Syn KO neurons, which was expected because γ-Syn levels in 
WT hippocampal neurons were already very low, and therefore could not be drastically reduced in γ-Syn 
KO neurons. These results are also in line with previous reports showing that β-Syn inhibits α-Syn 
aggregation in vitro(55, 56), as well as in vivo, as double transgenic mice co-expressing both human α- and 
β-Syn exhibit ameliorated motor deficits and lower α-Syn accumulation(37, 57). Our results however 
further suggest that the total levels or ratio of both endogenous α- and β-Syn could be critical in protecting 
against hα-Syn aggregation. Once this level drops below a certain threshold (either in the single or triple 
KOs), aggregation of hα-Syn into LB-like inclusions becomes progressive. Supporting this proposition is 
the observation that intermediate reduction of mα-Syn levels by shRNA did not promote hα-Syn inclusion 
formation in WT neurons. 
In summary, we have shown that two endogenous members of the synuclein family, mα-Syn and mβ-
Syn, attenuate the aggregation of over-expressed hα-Syn in mouse neurons. Taken together with the 
multitude of studies that have reported aggregation inhibition in the presence of amyloidogenic homologous 
proteins (such as Aβ, TTR, Haemoglobin and IAPP), this observation could reflect a more generic 
biological phenomenon, where endogenous homologues act as natural inhibitors of abnormal aggregation. 
Not only could this explain why most current rodent PD models relying on hα-Syn overexpression in WT 
mice do not show prominent hα-Syn fibrillization, but it also provides novel cellular and in vivo models 
that reproduce for the first time, the clear formation of fibrillar hα-Syn aggregates. The ability to 
quantitatively assess the dynamics of inclusion formation in these models provides unique opportunities to 
elucidate molecular and cellular determinants that influence the mechanisms of α-Syn fibrillization in living 
neurons, and the identification of pathways that modulate this process and contribute to neurodegeneration. 
Further studies using these models could allow identifying novel drugs for the treatment of PD based on 
modulating α-Syn aggregation and inter-neuronal spreading, or enhancing the degradation and clearance of 
toxic α-Syn aggregates. 
 
Materials and Methods 
Further experimental details are provided in SI Text. 
 
Primary neuron culture preparation, transfection, infection and Tolcapone treatment. Primary 
hippocampal neuronal cultures were prepared from P0 C57BL/6JRccHsd (WT, Harlan laboratories), 
C57BL/6JOlaHsd (α-Syn KO, Harlan laboratories)(12),  B6,129X1-Sncatm1Rosl/J (α-Syn KO, Jackson 
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laboratories)(13), β-Syn KO(31), γ-Syn KO(58), or α-β-γ-Syn KO mice(33) as previously described(10). 
Briefly, hippocampi were dissociated with papain and triturated using a glass pipette. After centrifugation 
at 400 g for 2 min, cells were plated in MEM/10% horse serum onto poly-L-lysine (Sigma) coated 
coverslips (glass 12mm, VWR, for immunocytochemistry; or thermanox plastic 13mm, Nunc, for TEM) at 
1.5 × 105 cells/ml, or at 3 × 105 cells/ml in 35mm confocal dishes (World Precision, for live imaging) or in 
10 cm dishes (BD Biosciences, for biochemical analysis). Medium was changed after 4 hrs to Neurobasal/ 
B27 medium, and neurons were treated with ARAC (Sigma) after 6 days-in-vitro (DIV) to stop glial 
division. At 7 DIV, neurons were either transiently transfected using LipofectamineTM 2000 (Invitrogen) 
according to manufacturer’s instructions for up to 3 days, or infected with lentiviruses at a multiplicity of 
infection of 10 for up to 7 days. When indicated, 24 hrs post-transfection, neurons were treated with 20 µM 
Tolcapone (Sigma) for an additional 24 hrs before immunocytochemistry. 
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Figures and legends 
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Fig. 1. The absence of mα-Syn promotes hα-Syn aggregation in primary neurons. (A) hα-Syn exhibits 
diffuse distribution in WT transfected neurons, and forms inclusions in cell bodies and neurites of SNCA-/- 
neurons. Orthogonal Z-stack projections are shown to verify the intra-cellular nature of inclusions. 
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Quantification of 25 neurons per condition (n=3 independent experiments) shows that significantly more 
SNCA-/- neurons develop inclusions (>1 µm in diameter). β3 tubulin staining was performed to reveal 
neurons. (B) Overexpressed hα-Syn reassumes its diffuse localization in SNCA-/- neurons upon restoring 
mα-Syn expression by transient transfection. Quantification of inclusion formation (>1µm) in 25 neurons 
per condition (n=3 independent experiments) shows significantly less inclusions formation in SNCA-/- 
neurons co-expressing both proteins. (C) Less monomeric hα-Syn is detected in nonionic detergent-soluble 
(Det. Sol.) fractions of lentivirally infected SNCA-/- neurons compared to WT counterparts. In contrast, 
nonionic detergent-insoluble (Det. Insol.) fractions of infected SNCA-/- neurons show more monomeric and 
HMW hα-Syn species, comparably to Det. Insol. fractions of WT neurons treated for 3 days with hα-Syn 
PFFs (0.5 µM). Actin was used to control for equal protein loading. Densitometric quantification (n=4 
independent experiments) of Det. Sol. hα-Syn reveals significantly decreased levels when expressed in 
SNCA-/- compared to WT neurons. In “A-C”, the Mann-Whiney test was applied to obtain P values 
(overlayed on histograms showing mean ± standard deviation (SD)). In “B-C”, hα-Syn and mα-Syn were 
differentially revealed using the Syn-211 and D37A6 antibodies, respectively. (D) Nine different anti-α-
Syn antibodies (epitopes in Table S1) detect inclusions in SNCA-/- neurons transfected with hα-Syn. (E) hα-
Syn inclusions in transfected SNCA-/- neurons exhibit LB-like pathology, as they are positive to Thioflavin-
S (lower panel), are phosphorylated at S129 (upper panel) and are ubiquitinated (middle panel). Co-
localization was confirmed by assessing regression coefficients (R2) of signals of both channels (shown in 
the upper right corner of the merged images). Scale bars denote 10 µm in “A-B” and 5 µm in “D-E”. 
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Fig. 2. Ultrastructure of hα-Syn inclusions in SNCA-/- neurons. (A) For CLEM analysis, a stained neuron 
was imaged by confocal microscopy, and then reprocessed and imaged by TEM resulting in a high 
resolution 3D acquisition of the same neuron. For illustration, the nucleus is rendered in blue, the cytosol 
in purple and inclusions in yellow. Scale bars denote 5µm. (B) To correlate between structures observed by 
ssTEM and fluorescence, single plane images were super-imposed (upper panel). High resolution images 
of inclusions (red boxes 1 and 2) are shown in the lower panel, with arrows indicating filamentous 
structures. The scale bar denotes 5 and 2 µm in the upper and lower panel, respectively. (C) The same 
analysis as in (B) but on different confocal and ssTEM planes from the same neuron shows heterogeneous 
filamentous content. (D) Most filaments observed by ssTEM (n=473) have a width ranging from 7-13 nm. 
The normal curve is shown in red, as well as values of mean ± SD. (E) Immuno-gold labelling of SNCA-/- 
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neurons expressing hα-Syn with the ab-6176 anti-Synuclein antibody establishes that filaments are positive 
for Synuclein. Four ssTEM images of different magnifications of the inclusion (blue arrowhead) and 
filaments (green arrowhead) are shown. The scale bar denotes 1 µm in the upper panel and 125 nm in the 
lower panel. (F) A 3D model of the inclusion (blue arrow in “E”) reveals a mesh of intertwining filamentous 
structures (in purple) with gold particles reacting with inner and outer portions. For illustration, the nucleus 
is rendered in blue, the inclusion in yellow, and immuno-gold particles in green. 
 
 
 
 
Fig. 3. hα-Syn inclusions in SNCA-/- neurons grow and incorporate soluble hα-Syn. (A) hα-Syn 
inclusions form 24 hrs post-transfection and grow over the next 24 hrs. 3D inclusion rendering and 
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quantification (n=25 neurons per condition) reveals significant inclusion volume increase at 48 and 72 hrs 
in MAP2 positive neurons. (B) mEOS2-α-Syn inclusions form 24 hrs post-transfection and grow over 72 
hrs of live imaging. 3D inclusion rendering and quantification (50 neurons per condition) reveals significant 
inclusion volume increase 72 hrs post-transfection. (C) mEOS2-α-Syn inclusions are immuno-positive for 
total α-Syn (Syn-1), pS129-α-Syn (WAKO) and ubiquitin. (D) mEOS2-Syn inclusions are immobile, and 
individually grow over ~1 hr of live imaging. Scale bars denote 5 µm in “A-C”, and 2 µm in “D”. (E) In 
FRAP experiments, inclusions were photo-bleached, and fluorescence recovery from diffusing soluble 
protein was monitored. In photo-conversion experiments, inclusion fluorescence was photo-converted from 
488 nm to 568 nm, and 568 nm fluorescence decay by diffusion out of inclusions was monitored. 
Fluorescence before, during and after inclusion (crossed circles) photo-bleaching (F) or photo-conversion 
(G) is shown. Middle panels show higher magnification of yellow boxes. Bottom panels show average plots 
(± SD) of normalized FRAP or photo-conversion (568 nm channel) recovery curves (n=87 or 63 inclusions, 
respectively). Scale bars denote 2 and 1 µm in lower and higher magnifications. (H) Values for immobile 
fractions and diffusion coefficients obtained from photo-conversion curves (n=50 inclusions) are 
significantly lower than those obtained by FRAP. In “A-B and H”, the Mann-Whiney test was applied to 
obtain P values (overlayed on box plots/violin scatter plots of individual values). 
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Fig. 4. Inclusion formation in SNCA-/- neurons reflects a hα-Syn aggregation driven process. (A) 
Whereas both hα-SynFL and hα-Syn∆120 form inclusions, the S87E aggregation deficient variant exhibits 
diffuse localization in SNCA-/- neurons 48 hrs post-transfection. Quantification of inclusion formation 
(>1µm) in 25 neurons per condition (mean ± SD, n=3 independent experiments) shows that significantly 
less α-SynS87E expressing neurons develop inclusions compared to α-SynFL and Syn∆120 counterparts. (B) 
Live imaging of SNCA-/- neurons expressing mEOS2-α-SynFL, mEOS2-α-SynS87E or mEOS2-α-Syn∆120 24 
hrs or 48 hrs post-transfection shows that mEOS2-α-SynS87E does not form prominent inclusions at both 
time-points. (C) 3D rendering of inclusion volume over 48 hrs post-transfection (50 neurons per condition) 
shows that whereas mEOS2-α-Syn∆120 forms significantly larger inclusions 24 hrs post-transfection 
compared to mEOS2-α-SynWT, the mEOS2-α-SynS87E mutant forms smaller inclusions at 48 hrs. Box plots 
overlaying violin scatter plots of individual values are shown. (D) SNCA-/- neurons expressing hα-Syn for 
24 hrs were treated either with DMSO or 20µM Tolcapone for an additional 24 hrs. Whereas DMSO treated 
neurons develop inclusions, those treated with Tolcapone exhibit diffuse hα-Syn localization. 
Quantification of inclusion formation (>1µm) in 25 neurons per condition (mean ± SD, n=3 independent 
experiments) shows that significantly less tolcapone treated transfected neurons develop inclusions 
compared to DMSO treated controls (right panel). In all panels scale bars denote 5 µm. In “A” one-way 
ANOVA/Scheffé test was applied, whereas in “C-D” the Mann-Whiney test was applied to obtain P values 
(overlayed on plots). 
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Fig. 5. Endogenous β-Syn KO naturally also acts as a hα-Syn aggregation inhibitor in primary 
neurons. (A) Immuno-cytochemistry validates loss of α- and β-Syn expression in α-Syn KO, β-Syn KO 
and triple Syn KO neurons compared to WT neurons. In contrast, γ-Syn immunoreactivity was not detected 
across conditions. (B) hα-Syn exhibits diffuse distribution in WT and γ-Syn KO transfected neurons, and 
forms inclusions (>1 µm) in cell bodies and neurites of β-Syn KO and triple Syn KO neurons. Quantification 
of 20 neurons per condition (mean ± SD, n=3 independent experiments) shows that significantly more β-
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Syn KO neurons and Triple KO neurons (one-way ANOVA, Scheffé) develop inclusions (>1 µm in 
diameter) compared to non-Tg neurons. (C) Inclusions formed in β-Syn KO and triple Syn KO neurons are 
hyper-phosphorylated at S129. Co-localization was confirmed by assessing regression coefficients (R2) of 
signals of both channels. The scale bar denotes 20 µm in “A”, and 5 µm in B-C. 
 
 
 
 
 
Fig. 6. The absence of mα-Syn promotes hα-Syn aggregation transgenic mice. (A) Less monomeric hα-
Syn is detected in detergent-soluble fractions from hα-Syn+/+SNCA-/- mice compared to hα-Syn+/+ 
counterparts, concomitant with appearance of HMW hα-Syn species in detergent-insoluble fractions. Loss 
of mα-Syn expression in SNCA-/- mice is verified using the mα-Syn specific antibody D37A6, and actin 
denotes equal protein loading. The asterisk refers to a nonspecific band. Densitometric quantification (n=3 
independent experiments) shows significantly decreased levels of cytosolic hα-Syn when expressed on 
SNCA-/- background. (B) hα-Syn+/+ and hα-Syn+/+SNCA-/- mice brains show strong hα-Syn expression in the 
neocortex, striatum and hippocampus that weakens upon PK treatment. High magnification analysis (insets) 
reveals intense proteinase-K resistant hα-Syn inclusions in hα-Syn+/+SNCA-/- mice. Scale bars denote 100 
µm in overviews and 15 µm in insets. Quantification of the number of cells with proteinase-K resistant hα-
Syn inclusions per 0.1 mm2 (n= 3 mice per condition) shows that significantly more inclusion bearing cells 
are detected in the neocortex and hippocampus of hα-Syn+/+SNCA-/- mice compared to hα-Syn+/+ mice. In 
“A-B”, the Mann-Whiney test was applied to obtain P values (overlayed on histograms showing mean ± 
SD). (C-D) Double positive hα-Syn inclusions for total α-Syn and pS129 α-Syn (C) or synaptophysin (D) 
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are detected in the cortex, striatum and hippocampus of hα-Syn+/+SNCA-/- mice. Orthogonal Z-stacks 
projections verify intracellular nature of inclusions. Scale bar denotes 5 µm. 
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Fig. 7. mα-Syn interacts with aggregated hα-Syn species and attenuates seeding and spreading.  (A) 
mα-Syn monomers (M) were incubated with equimolar amounts of hα-Syn M or sonicated fibrils (PFFs) 
before immuno-precipitation (IP) of hα-Syn. Following IP, mα-Syn was detected only in the sample 
comprising the mixture of mα-Syn and hα-Syn PFFs. Input solutions show similar protein levels before IP. 
The asterisks denote the heavy and light chains of the antibody used for IP. (B) hα-Syn M or hα-Syn PFFs 
were immobilized on a CM5 chip, and then increasing concentrations of mα-Syn M were flushed in to 
assess interaction kinetics by surface plasmon resonance (SPR). A response (interaction) was noted between 
immobilized hα-Syn PFF and injected mα-Syn M, and not with hα-Syn M. (C-F) hα-Syn M were incubated 
either alone (20 µM) or with 10% sonicated hα-Syn PFFs or mα-Syn PFFs, and aggregation kinetics were 
followed by: (C) ThT fluorescence, (D-E) assessing remaining soluble protein and (F) TEM analysis. (C-
E) Quantification of 3 independent experiments shows that mixtures of hα-Syn PFFs + hα-Syn M exhibit 
significantly higher ThT binding (C) and less soluble protein content (D-E) compared to hα-Syn M + mα-
Syn PFFs at early time-points (0-12 hours). The Mann-Whiney test was applied to obtain P values (P=0.04) 
from, and values of mean ± SD are shown. (F) TEM analysis shows that mixtures of hα-Syn PFFs + hα-
Syn M start forming fibrils after 8 hrs, compared to hα-Syn M alone or with mα-Syn PFFs which form 
oligomeric species at this timepoint. After 72 hrs, all three conditions show fibrillar morphology. (G) 
Immunohistochemistry shows compact somatic pS129-α-Syn inclusions (arrows) in the cingulate cortex, 
amygdala and striatum of WT mice injected with mα-Syn PFFs. In contrast, injection of hα-Syn PFFs in 
WT mice resulted in diffuse staining (arrowheads) in the cingulate cortex, and few somatic inclusions in 
the amygdala and striatum. Likewise, injection of either hα-Syn PFFs or mα-Syn PFFs in SNCA-/- mice 
resulted mostly in diffuse localization, with very few detected inclusions. Quantification of the number of 
cells showing pS129-α-Syn pathology per 0.1 mm2 (n= 5 mice per condition; mean ± SD) shows 
significantly more inclusions (Mann-Whitney test) in the cingulate cortex and amygdala of WT mice 
injected with mα-Syn PFFs compared to hα-Syn PFFs. In in SNCA-/- mice, no differences were noted across 
conditions. The scale bar denotes 200 nm in F and 100 µm in G. (H) Potential mechanism of hα-Syn 
aggregation inhibition by endogenous mα-Syn or mβ-Syn. In WT neurons, over-expressed monomeric hα-
Syn (green) misfolds into aggregation prone intermediates that form oligomers/protofibrils. Endogenous 
mα-Syn monomers (in red) or mβ-Syn (purple) preferentially interact with these hα-Syn species. This 
interaction attenuates the progressive incorporation of hα-Syn monomers, resulting in slower aggregation 
kinetics and decreased fibril formation. In SNCA-/- neurons or β-Syn KO neurons, as the combined levels of 
endogenous mα-Syn and mβ-Syn falls below a certain threshold, the inhibitory capping mechanism is 
reduced, and thus over-expressed hα-Syn aggregates more readily. 
